Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Simulations Plus, Inc. before investing.
In this article, we go over a few key elements for understanding Simulations Plus, Inc.’s stock price such as:
- Simulations Plus, Inc.’s current stock price and volume
- Why Simulations Plus, Inc.’s stock price changed recently
- Upgrades and downgrades for SLP from analysts
- SLP’s stock price momentum as measured by its relative strength
About Simulations Plus, Inc. (SLP)
Before we jump into Simulations Plus, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Want to learn more about Simulations Plus, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Simulations Plus, Inc..
Simulations Plus, Inc.’s Stock Price as of Market Close
As of July 02, 2026, 4:00 PM, CST, Simulations Plus, Inc.’s stock price was $18.390.
Simulations Plus, Inc. is up 0.22% from its previous closing price of $18.350.
During the last market session, Simulations Plus, Inc.’s stock traded between $18.340 and $18.470. Currently, there are approximately 20.16 million shares outstanding for Simulations Plus, Inc..
Simulations Plus, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.
Simulations Plus, Inc. Stock Price History
Simulations Plus, Inc.’s (SLP) price is currently up 0.44% so far this month.
During the month of July, Simulations Plus, Inc.’s stock price has reached a high of $18.500 and a low of $18.310.
Over the last year, Simulations Plus, Inc. has hit prices as high as $21.010 and as low as $11.090. Year to date, Simulations Plus, Inc.’s stock is up 0.88%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Simulations Plus, Inc. Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of July 02, 2026,, no analysts have changed their rating of Simulations Plus, Inc.’s stock over the last month.
Additionally, you'll want to evaluate Simulations Plus, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Simulations Plus, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Simulations Plus, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Simulations Plus, Inc. (SLP) by visiting AAII Stock Evaluator.
Relative Price Strength of Simulations Plus, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of July 02, 2026, Simulations Plus, Inc. has a weighted four-quarter relative price strength of 6.44%, which translates to a Momentum Score of 75 and is considered to be Strong.
Want to learn more about how Simulations Plus, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Simulations Plus, Inc. Stock Price: Bottom Line
As of July 2, 2026, Simulations Plus, Inc.’s stock price is $18.390, which is up 0.22% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Simulations Plus, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.